Hasil Pencarian - Tatyana A. Feldman

  • Menampilkan 1 - 5 hasil dari 5
Perbaiki Hasil
  1. 1
    Prevalence of non-Hodgkin lymphoma patients at high-risk of failure after CAR T-cell therapy eligible for bridging radiation therapy

    Prevalence of non-Hodgkin lymphoma patients at high-risk of failure after CAR T-cell therapy eligible for bridging radiation therapy oleh Adnan Danish, Adnan Danish, Alexandra Della Pia, Lindsay Fogel, Hassan Alkhatatneh, Charles Zhao, Tony Varughese, Karine A. Al Feghali, Lauren Pascual, Brittany Sinclaire, Michael Marafelias, Joshua Zenreich, Yen-Hong Kuo, Tatyana A. Feldman, Tatyana A. Feldman, Tatyana A. Feldman, Yi Zhang, Andre H. Goy, Andre H. Goy, Andre H. Goy, Andrew Ip, Andrew Ip, Andrew Ip, Scott D. Rowley, Scott D. Rowley, Scott D. Rowley

    Diterbitkan 2024-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Anti-spike antibody response to the COVID vaccine in lymphoma patients.

    Anti-spike antibody response to the COVID vaccine in lymphoma patients. oleh Alexandra Della Pia, Gee Youn Geeny Kim, Andrew Ip, Jaeil Ahn, Yanzhi Liu, Simone Kats, Michael Koropsak, Brittany Lukasik, Anamta Contractor, Krushna Amin, Lakshmi Ayyagari, Charles Zhao, Amolika Gupta, Mark Batistick, Lori A Leslie, Andre H Goy, Tatyana A Feldman

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Anti-spike antibody response to the COVID vaccine in lymphoma patients

    Anti-spike antibody response to the COVID vaccine in lymphoma patients oleh Alexandra Della Pia, Gee Youn (Geeny) Kim, Andrew Ip, Jaeil Ahn, Yanzhi Liu, Simone Kats, Michael Koropsak, Brittany Lukasik, Anamta Contractor, Krushna Amin, Lakshmi Ayyagari, Charles Zhao, Amolika Gupta, Mark Batistick, Lori A. Leslie, Andre H. Goy, Tatyana A. Feldman

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Safety and efficacy of tenalisib in combination with romidepsin in patients with relapsed/refractory T-cell lymphoma: results from a phase I/II open-label multicenter study

    Safety and efficacy of tenalisib in combination with romidepsin in patients with relapsed/refractory T-cell lymphoma: results from a phase I/II open-label multicenter study oleh Swaminathan P. Iyer, Auris Huen, Weiyun Z. Ai, Deepa Jagadeesh, Mary J. Lechowicz, Craig Okada, Tatyana A. Feldman, Paola Ghione, Juan P. Alderuccio, Rebecca Champion, Seo-Hyun Kim, Ann Mohrbacher, Kasi V. Routhu, Prajak Barde, Ajit M. Nair, Bradley M. Haverkos

    Diterbitkan 2023-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    P1064: BRENTUXIMAB VEDOTIN, NIVOLUMAB, DOXORUBICIN, AND DACARBAZINE FOR ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA: UPDATED EFFICACY AND SAFETY RESULTS FROM THE SINGLE ARM PHASE 2 STUDY

    P1064: BRENTUXIMAB VEDOTIN, NIVOLUMAB, DOXORUBICIN, AND DACARBAZINE FOR ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA: UPDATED EFFICACY AND SAFETY RESULTS FROM THE SINGLE ARM PHASE 2 S... oleh Chris Yasenchak, Ian W. Flinn, Jason Melear, Rod Ramchandren, Judah Friedman, John M. Burke, Yuliya Linhares, Paul Gonzales, Mihir Raval, Rangaswamy Chintapatla, Tatyana A. Feldman, Habte Yimer, Miguel Islas-Ohlmayer, Asad Dean, Vishal Rana, Mitul D. Gandhi, John Renshaw, Linda Ho, Michelle Fanale, Wenchuan Guo, Hun Ju Lee

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: